SG89492G - A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride - Google Patents
A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochlorideInfo
- Publication number
- SG89492G SG89492G SG894/92A SG89492A SG89492G SG 89492 G SG89492 G SG 89492G SG 894/92 A SG894/92 A SG 894/92A SG 89492 A SG89492 A SG 89492A SG 89492 G SG89492 G SG 89492G
- Authority
- SG
- Singapore
- Prior art keywords
- phenylmethyl
- dihydrochloride
- piperazinyl
- chlorophenyl
- ethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888827391A GB8827391D0 (en) | 1988-11-23 | 1988-11-23 | Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
SG89492G true SG89492G (en) | 1992-12-04 |
Family
ID=10647347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG894/92A SG89492G (en) | 1988-11-23 | 1992-09-05 | A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride |
Country Status (16)
Country | Link |
---|---|
KR (1) | KR970009728B1 (en) |
AT (1) | AT398971B (en) |
CA (1) | CA1317300C (en) |
CY (1) | CY1671A (en) |
DK (1) | DK174543B1 (en) |
ES (1) | ES2021907A6 (en) |
FI (1) | FI91862C (en) |
GB (2) | GB8827391D0 (en) |
GR (1) | GR1000553B (en) |
HK (1) | HK95892A (en) |
HU (1) | HU205094B (en) |
NO (1) | NO172342C (en) |
PH (1) | PH25982A (en) |
PL (1) | PL161379B1 (en) |
PT (1) | PT92364B (en) |
SG (1) | SG89492G (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08501561A (en) * | 1992-09-24 | 1996-02-20 | セプラコア,インコーポレイテッド | (-) Composition for treating allergic diseases using cetirizine |
WO1994006430A1 (en) * | 1992-09-24 | 1994-03-31 | Sepracor, Inc. | Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
AU703690B2 (en) * | 1992-09-24 | 1999-04-01 | Sepracor, Inc. | Methods for treating allergic disorders using optically pure (+)cetirizine |
GB9305282D0 (en) * | 1993-03-15 | 1993-05-05 | Ucb Sa | Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine |
US6469009B1 (en) | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
BE1010095A3 (en) * | 1996-04-10 | 1997-12-02 | Ucb Sa | METHOD OF PREPARATION OF ACID 2- [2- [4 - [(4-Chlorophenyl) phenylmethyl] -1-PIPERAZINYL] ETHOXY] acetic acid AND ITS SALTS. |
BE1010094A3 (en) * | 1996-04-10 | 1997-12-02 | Ucb Sa | NEW [2- (1-piperazinyl) ethoxy] SUBSTITUTED. |
EP1020443B1 (en) | 1997-06-04 | 2003-09-10 | Azwell Inc. | Process for producing piperazinesulfonamide derivatives and salts thereof |
EP0919550A1 (en) | 1997-11-26 | 1999-06-02 | Ucb, S.A. | Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride |
IL124195A (en) * | 1998-04-23 | 2000-08-31 | Chemagis Ltd | Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid |
GR990100135A (en) * | 1999-04-22 | 2000-12-29 | Genepharm �.�. | Method of preparation 2-(2-{4-[(4-chlorophenyl)(phenyl)methhyl]piperasine}-ethoxy)acetic acid and its bihydrochloric salt |
JP2002249487A (en) | 2001-02-22 | 2002-09-06 | Sumitomo Chem Co Ltd | 4-(tert-butoxycarbonyl)piperazine derivative, optically active acid addition salt of the same, method for producing them and optically active 1-[(substituted phenyl)phenylmethylpiperazine which uses them |
US6977301B1 (en) | 2001-05-29 | 2005-12-20 | Ucb, S.A. | Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide |
US7199241B1 (en) | 2001-05-29 | 2007-04-03 | Ucb, S.A. | Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide |
CA2514145A1 (en) | 2003-01-23 | 2004-08-05 | Ucb Farchim Sa | Piperazine derivatives and their use as synthesis intermediates |
KR100503443B1 (en) | 2004-02-02 | 2005-07-22 | 한림제약(주) | Processes for preparing an optically active cetirizine or its salt |
NZ556580A (en) * | 2005-03-03 | 2009-08-28 | Ucb Farchim Sa | Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
HU227325B1 (en) * | 2005-12-08 | 2011-03-28 | Egis Gyogyszergyar Nyrt | Process for the production of an intermediate of (dextro- and levo)- cetirizine |
EP2121643B1 (en) | 2007-03-12 | 2013-10-23 | Krka, tovarna zdravil, d.d., Novo mesto | New process for the preparation of levocetirizine and intermediates thereof |
SI22489A (en) * | 2007-03-12 | 2008-10-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | New procedure for preparation of levocetirizine and its intermediates |
US8084606B2 (en) | 2007-06-15 | 2011-12-27 | Symed Labs Limited | Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates |
WO2009062036A2 (en) * | 2007-11-09 | 2009-05-14 | Dr. Reddy's Laboratories Ltd. | Processes for preparing levocetirizine and pharmaceutically acceptable salts thereof |
US7989623B2 (en) | 2007-11-21 | 2011-08-02 | Synthon Bv | Process for making n-(diphenylmethyl)piperazines |
ATE499352T1 (en) | 2007-11-21 | 2011-03-15 | Synthon Bv | METHOD FOR PRODUCING N-(DIPHENYLMETHYL)PIPERAZINES |
KR20110022635A (en) | 2008-06-02 | 2011-03-07 | 시플라 리미티드 | Processes for the synthesis of levocetirizine and intermediates for use therein |
EP2297122B1 (en) * | 2008-06-11 | 2014-05-21 | KRKA, tovarna zdravil, d.d., Novo mesto | New process for the preparation of levocetirizine and intermediates thereof |
KR100998067B1 (en) | 2008-09-08 | 2010-12-03 | 주식회사 삼오제약 | A novel Bis1-[4-chlorophenylphenylmethyl]piperazine-2,3-Dibenzoyl tartarate intermediate salt and the method for isolating optically active 1-[4-chlorophenylphenylmethyl]piperazine using thereby |
WO2010046908A2 (en) | 2008-09-17 | 2010-04-29 | Calyx Chemicals And Pharmaceuticals Pvt. Ltd. | Novel water based process for the preparation of substituted diphenylmethyl piperazines |
WO2010107404A1 (en) | 2009-03-16 | 2010-09-23 | Mahmut Bilgic | Stable pharmaceutical combinations |
TR201007652A2 (en) | 2010-09-20 | 2012-04-24 | Bi̇lgi̇ç Mahmut | Synergistic effect. |
TR201009398A2 (en) | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Tablet formulations with improved physical properties |
WO2012101475A1 (en) | 2011-01-27 | 2012-08-02 | Jubilant Life Sciences Limited | An improved process for the preparation of antihistaminic drugs via a novel carbamate intermediate |
CN103044355A (en) * | 2011-10-13 | 2013-04-17 | 湖南九典制药有限公司 | Key intermediate for synthesizing levocetirizine and preparation method thereof |
KR101418404B1 (en) | 2012-01-06 | 2014-07-10 | 한미약품 주식회사 | Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof |
KR102226833B1 (en) | 2013-06-28 | 2021-03-12 | 한미약품 주식회사 | Complex granule formulation having improved stability comprising levocetirizine and montelukast |
CN104045607B (en) * | 2014-05-21 | 2016-04-13 | 丽珠医药集团股份有限公司 | A kind of purification process of cetrizine hcl |
CN105924409B (en) * | 2016-05-12 | 2019-01-08 | 浙江永宁药业股份有限公司 | The method for splitting of one kind (R) -1- ((2- chlorphenyl)-(phenyl)-methyl)-piperazine |
CN111205247B (en) * | 2020-04-22 | 2020-08-14 | 湖南九典宏阳制药有限公司 | Preparation method of levocetirizine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI75816C (en) * | 1981-02-06 | 1988-08-08 | Ucb Sa | Process for the preparation of therapeutically active 2- [4- (diphenylmethyl) -1-piperazinyl] -acetic acid or its amide |
-
1988
- 1988-11-23 GB GB888827391A patent/GB8827391D0/en active Pending
-
1989
- 1989-09-29 CA CA000614709A patent/CA1317300C/en not_active Expired - Fee Related
- 1989-11-20 GR GR890100770A patent/GR1000553B/en not_active IP Right Cessation
- 1989-11-21 PT PT92364A patent/PT92364B/en not_active IP Right Cessation
- 1989-11-21 GB GB8926243A patent/GB2225321B/en not_active Expired - Lifetime
- 1989-11-22 FI FI895564A patent/FI91862C/en not_active IP Right Cessation
- 1989-11-22 AT AT0266589A patent/AT398971B/en not_active IP Right Cessation
- 1989-11-22 DK DK198905867A patent/DK174543B1/en not_active IP Right Cessation
- 1989-11-22 PL PL1989282410A patent/PL161379B1/en unknown
- 1989-11-22 ES ES8903975A patent/ES2021907A6/en not_active Expired - Lifetime
- 1989-11-22 HU HU896131A patent/HU205094B/en not_active IP Right Cessation
- 1989-11-22 NO NO894651A patent/NO172342C/en not_active IP Right Cessation
- 1989-11-23 PH PH39570A patent/PH25982A/en unknown
- 1989-11-23 KR KR1019890017040A patent/KR970009728B1/en not_active IP Right Cessation
-
1992
- 1992-09-05 SG SG894/92A patent/SG89492G/en unknown
- 1992-12-03 HK HK958/92A patent/HK95892A/en not_active IP Right Cessation
-
1993
- 1993-05-14 CY CY1671A patent/CY1671A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB2225321A (en) | 1990-05-30 |
DK586789A (en) | 1990-05-24 |
ATA266589A (en) | 1994-07-15 |
KR900007825A (en) | 1990-06-02 |
DK174543B1 (en) | 2003-05-19 |
NO894651D0 (en) | 1989-11-22 |
NO172342C (en) | 1993-07-07 |
FI895564A0 (en) | 1989-11-22 |
PL161379B1 (en) | 1993-06-30 |
HU205094B (en) | 1992-03-30 |
PT92364A (en) | 1990-05-31 |
HU896131D0 (en) | 1990-02-28 |
AT398971B (en) | 1995-02-27 |
DK586789D0 (en) | 1989-11-22 |
HK95892A (en) | 1992-12-11 |
GR1000553B (en) | 1992-08-26 |
GB2225321B (en) | 1992-04-08 |
GB8926243D0 (en) | 1990-01-10 |
FI91862C (en) | 1994-08-25 |
KR970009728B1 (en) | 1997-06-17 |
NO894651L (en) | 1990-05-25 |
CY1671A (en) | 1993-05-14 |
NO172342B (en) | 1993-03-29 |
PT92364B (en) | 1995-07-18 |
ES2021907A6 (en) | 1991-11-16 |
FI91862B (en) | 1994-05-13 |
CA1317300C (en) | 1993-05-04 |
HUT53627A (en) | 1990-11-28 |
GB8827391D0 (en) | 1988-12-29 |
GR890100770A (en) | 1990-12-31 |
PH25982A (en) | 1992-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2225321B (en) | A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride | |
GB2225320B (en) | A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride | |
NO168771C (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF THE THERAPEUTIC ACTIVE COMPOUND 11- (4- (2- (2-HYDROXYETOXY) ETHYL) -1-PIPERAZINYL) DIBENZO (B, F) - (1,4) -TIAZEPINE AND PHARMASOEPTY SISTEEPLE | |
HK1024232A1 (en) | Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl)piperazines | |
HU9700744D0 (en) | Process for the manufacture of 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]-ethoxy]-acetic acid and its salts | |
DK164364C (en) | 4- (ISOXAZOLYL) -THIAZOL-2-OXAMIC ACID COMPOUNDS, A PROCEDURE FOR PREPARING IT, AN INTERMEDIATE USE OF THE PROCEDURE, AND A PHARMACEUTICAL PREPARATION | |
PL287224A1 (en) | Method of obtaining 2-(2-(4-(/4-chlorophenyl/phenylmethyl)-1-piperazinyl) ethoxy) acetic acid and its dihydrohloride | |
ZA82752B (en) | 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acids and their amides | |
JPS6447776A (en) | 1-(2-(phenylmethyl)phenyl)piperazine compound, manufacture and medicinal composition | |
PH24912A (en) | 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives | |
IL63031A0 (en) | 2-(2-aminothiazol-4-yl)-n-(imidazolidin-2-on-1-yl)-2-iminoacetylaminocephalosporanic acid in pure syn-form,their production and syn-acids used therein | |
GB2216417B (en) | New uses of 4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid | |
ZA891858B (en) | New uses of 4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid | |
FI98728B (en) | Process for preparing a therapeutically utilizable 2,3,4,5,6,7-hexahydro-1-(4-{1-/4-(2- methoxyphenyl)piperazinyl/}-2-phenylbutyryl)-1H-azepine or a pharmaceutically acceptable acid addition salt thereof | |
CS224688A1 (en) | 2-(biphenyl-4-yl)-5-phenyl-1,3,4-oxadiazole-4-carboxyl acid and its salts and method of their production | |
CS8904695A2 (en) | Method of 2-(4-(2-(1-piperidinyl)-ethoxyl benzoyl) benzoic acid's 1-(4-amino-oxo-3,3-difenylbutyl)-1-methylpiperidinium bromide and methylester in liquid medicamentous forms determination |